Inactive Instrument
Quotes Chromadex Corp OTC Bulletin Board
Stocks
CDXC
US1710771007
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 05-21 | NARB recommends Niagen modify/discontinue certain Tru Niagen NAD+ dietary supplement claims | RE |
| 05-06 | Niagen Bioscience, Inc., Q1 2026 Earnings Call, May 06, 2026 |
Basic data
Market Cap (USD)
272,954,738
Net sales (USD)
129,423,000
Free-Float
70.75 %
Free-Float capitalization (USD)
192,700,474
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 273M | |
| -0.48% | +7.20% | -5.08% | +2.45% | 46.2B | |
| +2.19% | +11.71% | +393.31% | +609.31% | 38.71B | |
| +2.53% | +13.93% | +21.38% | -10.96% | 31.9B | |
| +1.65% | +3.61% | +16.04% | +55.24% | 31.12B | |
| -4.16% | -2.58% | +8.74% | +15.22% | 23.77B | |
| -0.32% | +12.96% | - | - | 16.2B | |
| +1.37% | +14.53% | +69.64% | +136.34% | 15.05B | |
| +1.00% | +10.30% | +13.31% | +23.36% | 13.74B | |
| +3.63% | +9.53% | +103.97% | +106.25% | 13.42B | |
| Average | +0.82% | +9.11% | +77.66% | +117.15% | 23.04B | |
| Weighted average by Cap. | +0.75% | +8.71% | +88.85% | +136.64% |
Historical Quotes: Chromadex Corp
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- NAGE Stock
- CDXC Stock
- Quotes Chromadex Corp
Select your edition
All financial news and data tailored to specific country editions
